Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung Carcinoma
Sun Yat-sen University
Sun Yat-sen University
Eastern Cooperative Oncology Group
Roswell Park Cancer Institute
Bristol-Myers Squibb
Hoffmann-La Roche
Incyte Corporation
University of Maryland, Baltimore
West Virginia University
Hoffmann-La Roche
Alliance for Clinical Trials in Oncology
Washington University School of Medicine
Eastern Cooperative Oncology Group
Louisiana State University Health Sciences Center Shreveport
Pfizer
Spectrum Pharmaceuticals, Inc